Table 1. Characteristics of the studies included. The main characteristics of the studies regarding the place where they were conducted, the inclusion criteria for participants and the follow-up to assess recurrences is shown*.
Region | First author | Blood schizonticide + Intervention/comparison | Dose adjustment for body weight greater than 60 kg | Endemic region | Population | Inclusion criteria parasitemia diagnosis day (# parasites/µl) | G6PDH test before administering PQ | Simultaneous treatment blood schizonticide and PQ | Supervision treatment | Genoyping for clasiffication recurrences (relapse or reinfection) |
---|---|---|---|---|---|---|---|---|---|---|
America | Pinto, et al 18 Brazil | CQ 10 mg/kg single dose + PQ 0.5 mg/kg/day 7 days | Not applicable | Yes | Community, children between 0 and 15 years old | No | No | Not specified | Not specified | No |
Abdon, et al 15 Brazil | CQ 25 mg/kg 3 days + PQ 0.25 mg/kg/day 14 days | Not specified | Yes | Community, age higher than 12 years | No | Not specified | Not specified | Yes | No | |
CQ 10 mg/kg single dose + PQ 0.5 mg/kg/day 7 days | Not specified | Yes | ||||||||
Solari-Soto, et al 20 Peru | CQ 25 mg/Kg + PQ 0.25 mg/kg/day 14 days | Not specified | Yes | Community, age higher than 12 years | No | Not specified | Yes | Yes | No | |
CQ 25 mg/Kg + PQ 0.5 mg/kg/day 7 days | Yes | |||||||||
Da Silva, et al 16 Brazil | AS 50 mg 0h and 12h + PQ 30 mg/d 7 days | No | Yes | Community, age higher than 14 years | No | Not specified | Not specified | Not specified | No | |
AS 100 mg 0h and 12h + PQ 30 mg/d 7 days | ||||||||||
AS 100 mg 0h and 50 mg 12h + PQ 30 mg/d 7 days | ||||||||||
CQ 600mg single dose + PQ 30 mg/kg/d 7 days | ||||||||||
Carmona-Fonseca, et al 21 Colombia | CQ 25mg/Kg in 3 days + PQ 210 mg in 7 days | Not specified | Yes | Community, children under18 years old | Yes; 1000 or more parasites/µl | Yes | Yes | Yes | No | |
Durand, et al 17 Perú | CQ 25 mg / kg 3días + PQ 0,5 mg/kg/day 7 days | Not specified | Yes | Community, age higher than 1 year | Yes; between 250 - 100000 parasites/µl | Yes | Yes | Yes | Yes | |
CQ 25 mg/kg 3 días + PQ 0,25 mg/kg/day 14 days | Not specified | Yes | Yes | |||||||
Southeast Asian | Sutanto, et al 23 Indonesia | Quinina (10 mg/kg 3 time by day, 7 days) + PQ 30 mg/day 14 days | Yes; maximum 45 mg/day, PQ in participant greater than 70 kg. | No | Soldiers | No | Yes | Yes | Not specified | Not applicable. All recurrences are relapse |
Dihidroartemisinina (120 mg) - piperaquina (960 mg)/day, 3 days + PQ after day 28; 30 mg/day, 14 days | No; PQ after finishing blood schizonticide | Not specified | ||||||||
Rajgor, et al 19 India | CQ 25 mg/kg 3 days + PQ 15mg/day, 14 days | Not specified | Yes | Community, age higher than 18 years | No | Yes | No, PQ 24 hours after last CQ dosage | Yes | Yes | |
CQ 25 mg/kg 3 days + PQ 30 mg/day, 7 days | ||||||||||
CQ 25 mg/kg 3 days + PQ 30 mg/day, 14 days | ||||||||||
Eastern Mediterranean | Leslie, et al 22 2008 Pakistan | CQ 25 mg/kg 3 days + PQ 0.5 mg/kg/day, 14 days | Not specified | Yes | Community, age higher than 3 years | No | Yes | Yes | Yes | No |
G6PDH, Glucose 6-phosphate deshidrogenase, PQ, Primaquine, CQ, Chloroquine, AS, Artesunate
* All diagnosis test were made by microscopy